inspiration, page-58

Time line / Steps to the MPA.

1.Submission of draft report by 21^st of November 2017 - Completed on time, and in the hands of NLC / NMDC on 22/11

2.Presentation to NLC & NMDC by 5^th of December 2017 -
IMO...ECT should be advised of outcome after the presentation. Will there be a need to make changes to commercial agreements? What does ECT management have up their sleeves, if, there is a need to renegotiate terms? Will there be enough time, to finalize the report. This is the key step...imo

3.Final report by 19^th of December 2017

4.Report passed on to Coal and Steel Ministers for approval

5.Report passed on to Niti Aayog for approval , Policy Alignment and Assessment

6.Report passed back to NLC / NMDC for that elusive board Approval.

7.MPA Signing ceremony

Reminder - The DD is all about this -

Limited Tender for the review of the financial and structural aspects of the Integrated Project proposed under the Master Project Agreement (MPA).
This split approximates the expected cumulative position of all expenditures made by each party from inception of the technologies through to the conclusion of the operational period of the integrated demonstration project. That is, commencing with ECT’s listing (2006) through to the construction and operation of the integrated demonstration project under the MPA.

Financial Consultancy:
>Analyse ECT Aust audited accounts to ascertain the expenditure recognized and assets acquired in the development & acquisition of technologies Coldry and Matmor.
. Including original fair value of assets acquired (APCS) by ECT on commencement of the company as at 25th May 2006
.Operating expenditure over the period 2006-present
.Technology purchases directly related to Coldry and Matmor
.Future funding committed by ECT to pilot plant project under the proposed MPA
>Compare results of this analysis with the proposed funding by NLC / NMDC in the project to verify the proportioned equity distribution at conversion of ECT India being:
.ECT - 75%
.NLC - 12.5%
.NMDC - 12.5%

GL